cotinine has been researched along with Demyelinating Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ascherio, A; Barro, C; Cortese, M; Edan, G; Foley, FW; Fox, EJ; Freedman, MS; Hartung, HP; Hemmer, B; Kappos, L; Kuhle, J; MartĂnez-Lapiscina, EH; Montalbán, X; Munger, KL; Penner, IK; Schippling, S; Wicklein, EM | 1 |
1 trial(s) available for cotinine and Demyelinating Diseases
Article | Year |
---|---|
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Topics: Adjuvants, Immunologic; Antibodies, Viral; Biomarkers; Cognition; Cotinine; Demyelinating Diseases; Double-Blind Method; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Interferon beta-1b; Male; Multiple Sclerosis, Relapsing-Remitting; Neurofilament Proteins; Risk Factors; Smoking; Time; Vitamin D | 2020 |